IL-18 is required for self-reactive T cell expansion in NOD mice

Journal of Autoimmunity

Volumn 36, Issue 3-4, 2011, Pages 263-277

  Marleau, Annette M ^a,b   Sarvetnick, Nora E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

IL 18; T cells; Type 1 diabetes

Indexed keywords

INTERLEUKIN 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; RECEPTORS, INTERLEUKIN-18; T-LYMPHOCYTES;

EID: 79954970170     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.02.005     Document Type: Article

References (53)

1. Trembleau S., Penna G., Gregori S., Chapman H.D., Serreze D.V., Magram J., et al. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol 1999, 163:2960-2968.
2. Savinov A.Y., Wong F.S., Chervonsky A.V. IFN-gamma affects homing of diabetogenic T cells. J Immunol 2001, 167:6637-6643.
3. Hill N.J., Van Gunst K., Sarvetnick N. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. J Immunol 2003, 170:1649-1658.
4. Campbell I.L., Iscaro A., Harrison L.C. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J Immunol 1988, 141:2325-2329.
5. Suk K., Kim S., Kim Y.H., Kim K.A., Chang I., Yagita H., et al. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 2001, 166:4481-4489.
6. Trembleau S., Penna G., Gregori S., Giarratana N., Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J Immunol 2003, 170:5491-5501.
7. Serreze D.V., Post C.M., Chapman H.D., Johnson E.A., Lu B., Rothman P.B. Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 2000, 49:2007-2011.
8. Hultgren B., Huang X., Dybdal N., Stewart T.A. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996, 45:812-817.
9. Campbell I.L., Oxbrow L., Harrison L.C. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J Autoimmun 1991, 4:249-262.
10. Sobel D.O., Han J., Williams J., Yoon J.W., Jun H.S., Ahvazi B. Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse. J Autoimmun 2002, 19:129-137.
11. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
12. Bending D., De La Pena H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009.
13. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 2009, 39:216-224.
14. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
15. Lamkanfi M., Dixit V.M. The inflammasomes. PLoS Pathog 2009, 5:e1000510.
16. Ahn H.J., Maruo S., Tomura M., Mu J., Hamaoka T., Nakanishi K., et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J Immunol 1997, 159:2125-2131.
17. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998, 161:3400-3407.
18. Smeltz R.B., Chen J., Hu-Li J., Shevach E.M. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4. J Exp Med 2001, 194:143-153.
19. + T cell turnover in vivo by IL-12, IL-18, and IFN-gamma. J Immunol 2001, 166:6007-6011.
20. + T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 2001, 166:1097-1105.
21. + T cells: activation with high-dose IL-2 renders naïve T cells responsive to IL-12 and/or IL-18 in the absence of TCR ligation. Eur J Immunol 2003, 33:1788-1798.
22. + T cells by lipopolysaccharide-induced IL-12 and IL-18. J Immunol 2004, 173:6873-6881.
23. Lewis E.C., Dinarello C.A. Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci U S A 2006, 103:16852-16857.
24. Frigerio S., Hollander G.A., Zumsteg U. Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Horm Res 2002, 57:94-104.
25. Rothe H., Hibino T., Itoh Y., Kolb H., Martin S. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. J Autoimmun 1997, 10:251-256.
26. Dinarello C.A. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007, 27:98-114.
27. Shi F.D., Takeda K., Akira S., Sarvetnick N., Ljunggren H.G. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol 2000, 165:3099-3104.
28. Rothe H., Jenkins N.A., Copeland N.G., Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 1997, 99:469-474.
29. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997, 186:1663-1676.
30. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993, 74:1089-1100.
31. Hill N.J., Stotland A., Solomon M., Secrest P., Getzoff E., Sarvetnick N. Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes. Biol Direct 2007, 2:5.
32. Wells A.D., Gudmundsdottir H., Turka L.A. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997, 100:3173-3183.
33. Fantuzzi G., Reed D.A., Dinarello C.A. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 1999, 104:761-767.
34. Puren A.J., Fantuzzi G., Dinarello C.A. Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci U S A 1999, 96:2256-2261.
35. Ito H., Esashi E., Akiyama T., Inoue J., Miyajima A. IL-18 produced by thymic epithelial cells induces development of dendritic cells with CD11b in the fetal thymus. Int Immunol 2006, 18:1253-1263.
36. McAleer M.A., Reifsnyder P., Palmer S.M., Prochazka M., Love J.M., Copeman J.B., et al. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 1995, 44:1186-1195.
37. Tough D.F., Sprent J. Turnover of naïve- and memory-phenotype T cells. J Exp Med 1994, 179:1127-1135.
38. Min B., Foucras G., Meier-Schellersheim M., Paul W.E. Spontaneous proliferation, a response of naïve CD4 T cells determined by the diversity of the memory cell repertoire. Proc Natl Acad Sci U S A 2004, 101:3874-3879.
39. + T-cell phenotype in vivo. Eur J Immunol 2009, 39:67-77.
40. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
41. Surh C.D., Boyman O., Purton J.F., Sprent J. Homeostasis of memory T cells. Immunol Rev 2006, 211:154-163.
42. Rodriguez-Galan M.C., Bream J.H., Farr A., Young H.A. Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. J Immunol 2005, 174:2796-2804.
43. Le Campion A., Gagnerault M.C., Auffray C., Becourt C., Poitrasson-Riviere M., Lallemand E., et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 2009, 114:1784-1793.
44. King C., Ilic A., Koelsch K., Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265-277.
45. Pejnovic N., Vratimos A., Lee S.H., Popadic D., Takeda K., Akira S., et al. Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet. Mol Immunol 2009, 47:37-45.
46. Sakai A., Sugawara Y., Kuroishi T., Sasano T., Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008, 181:2898-2906.
47. Oikawa Y., Shimada A., Kasuga A., Morimoto J., Osaki T., Tahara H., et al. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. J Immunol 2003, 171:5865-5875.
48. Nicoletti F., Di Marco R., Papaccio G., Conget I., Gomis R., Bernardini R., et al. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol 2003, 33:2278-2286.
49. Zaccone P., Phillips J., Conget I., Cooke A., Nicoletti F. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol 2005, 115:74-79.
50. Rothe H., Hausmann A., Casteels K., Okamura H., Kurimoto M., Burkart V., et al. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J Immunol 1999, 163:1230-1236.
51. Schott W.H., Haskell B.D., Tse H.M., Milton M.J., Piganelli J.D., Choisy-Rossi C.M., et al. Caspase-1 is not required for type 1 diabetes in the NOD mouse. Diabetes 2004, 53:99-104.
52. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12:650-656.
53. Katakami N., Kaneto H., Matsuhisa M., Yoshiuchi K., Kato K., Yamamoto K., et al. Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients. Diabetes Care 2007, 30:159-161.